Stock Research for EPZM

EPZM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

EPZM Stock Chart & Research Data

The EPZM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EPZM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EPZM Due diligence Resources & Stock Charts

The EPZM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EPZM Detailed Price Forecast - CNN Money CNN View EPZM Detailed Summary - Google Finance
Yahoo View EPZM Detailed Summary - Yahoo! Finance Zacks View EPZM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View EPZM Trends & Analysis - Trade-Ideas Barrons View EPZM Major Holders - Barrons
NASDAQ View EPZM Call Transcripts - NASDAQ Seeking View EPZM Breaking News & Analysis - Seeking Alpha
Spotlight View EPZM Annual Report - CompanySpotlight.com OTC Report View EPZM OTC Short Report - OTCShortReport.com
TradeKing View EPZM Fundamentals - TradeKing Charts View EPZM SEC Filings - Bar Chart
WSJ View Historical Prices for EPZM - The WSJ Morningstar View Performance/Total Return for EPZM - Morningstar
MarketWatch View the Analyst Estimates for EPZM - MarketWatch CNBC View the Earnings History for EPZM - CNBC
StockMarketWatch View the EPZM Earnings - StockMarketWatch MacroAxis View EPZM Buy or Sell Recommendations - MacroAxis
Bullish View the EPZM Bullish Patterns - American Bulls Short Pains View EPZM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View EPZM Stock Mentions - StockTwits PennyStocks View EPZM Stock Mentions - PennyStockTweets
Twitter View EPZM Stock Mentions - Twitter Invest Hub View EPZM Investment Forum News - Investor Hub
Yahoo View EPZM Stock Mentions - Yahoo! Message Board Seeking Alpha View EPZM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for EPZM - SECform4.com Insider Cow View Insider Transactions for EPZM - Insider Cow
CNBC View EPZM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EPZM - OTC Markets
Yahoo View Insider Transactions for EPZM - Yahoo! Finance NASDAQ View Institutional Holdings for EPZM - NASDAQ


Stock Charts

FinViz View EPZM Stock Insight & Charts - FinViz.com StockCharts View EPZM Investment Charts - StockCharts.com
BarChart View EPZM Stock Overview & Charts - BarChart Trading View View EPZM User Generated Charts - Trading View




Latest Financial News for EPZM


Epizyme Announces Closing of Concurrent Public Offerings and Full Exercise of Underwriter’s Option to Purchase Additional Shares
Posted on Tuesday March 12, 2019

Epizyme, Inc. (EPZM), a late-stage company developing novel epigenetic therapies, today announced the closing of its two concurrent underwritten public offerings of 11,500,000 shares of its common stock and 350,000 shares of its non-voting Series A Convertible Preferred Stock, which includes the full exercise by the underwriters of their separate options in each of the respective offerings to purchase additional shares at the public offering price. The public offering price of each share of common stock was $11.50 and the public offering price of each share of Series A stock was $115.00. The aggregate gross proceeds to Epizyme from the offerings, before deducting underwriting discounts and offering expenses, are $172.50 million.


Does Epizyme, Inc.’s (NASDAQ:EPZM) CEO Salary Compare Well With Others?
Posted on Friday March 08, 2019

Rob Bazemore has been the CEO of Epizyme, Inc. (NASDAQ:EPZM) since 2015. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. After that,Read More...


Epizyme Announces Pricing of Concurrent Public Offerings of Common Stock and Series A Preferred Stock
Posted on Wednesday March 06, 2019

Epizyme, Inc. (EPZM), a late-stage company developing novel epigenetic therapies, today announced the pricing of two concurrent underwritten public offerings of (i) 10,000,000 shares of its common stock and (ii) 304,348 shares of its non-voting Series A Convertible Preferred Stock. Epizyme anticipates the total gross proceeds from the offering (before deducting underwriting discounts and offering expenses) will be approximately $150 million, excluding any exercise of the underwriters' options to purchase additional shares and before deducting underwriting discounts and offering expenses. The public offering price of each share of common stock is $11.50 and the public offering price of each share of Series A stock is $115.00.


Epizyme Announces Proposed Concurrent Public Offerings of Common Stock and Series A Preferred Stock
Posted on Wednesday March 06, 2019

Epizyme, Inc. (EPZM), a late-stage company developing novel epigenetic therapies, today announced that it intends to offer and sell shares of its common stock and Series A convertible preferred stock in two concurrent but separate underwritten public offerings. The offerings are being made by means of separate preliminary prospectus supplements and are not contingent upon each other. Epizyme also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock and preferred stock offered in the offering.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.